JPS56123919A - Remedy and preventive for diabetes - Google Patents
Remedy and preventive for diabetesInfo
- Publication number
- JPS56123919A JPS56123919A JP2409081A JP2409081A JPS56123919A JP S56123919 A JPS56123919 A JP S56123919A JP 2409081 A JP2409081 A JP 2409081A JP 2409081 A JP2409081 A JP 2409081A JP S56123919 A JPS56123919 A JP S56123919A
- Authority
- JP
- Japan
- Prior art keywords
- insulin secretion
- secretion promoting
- mammals
- novel
- fraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
PURPOSE: To provide the titled drug containing an insulin secretion promoting active fraction produced by a specific microorganism as an effective component.
CONSTITUTION: Microorganism capable of producing insulin secretion promoting active component and belonging to Bordetella pertussis phase I or II, is cultured, and the fraction obtained from the culturing product, especially a novel proteinous substance YH7512, is used as an effective component of the titled drug. The fraction promotes the insulin secretion of mammals, and nevertheless, keeps the blood sugar level to the normal level. It is administered to the patient most pref. by intravenous injection. The novel proteinous substance YH7512 is nondeliquescent white powder and has a molecular weight of 77,000±6,400 and an isoelectric point of 8.4±0.5. It has insulin secretion promoting effect and sugar resistance improving activity to mammals, and the effects lasts for several weeks to several months by single admistration.
COPYRIGHT: (C)1981,JPO&Japio
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56024090A JPS5946928B2 (en) | 1981-02-20 | 1981-02-20 | Diabetic treatment and prevention drugs |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56024090A JPS5946928B2 (en) | 1981-02-20 | 1981-02-20 | Diabetic treatment and prevention drugs |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1039777A Division JPS5396392A (en) | 1977-02-01 | 1977-02-01 | Active substance for increasing secretion of insulin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS56123919A true JPS56123919A (en) | 1981-09-29 |
| JPS5946928B2 JPS5946928B2 (en) | 1984-11-15 |
Family
ID=12128681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56024090A Expired JPS5946928B2 (en) | 1981-02-20 | 1981-02-20 | Diabetic treatment and prevention drugs |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5946928B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019195911A1 (en) | 2018-04-10 | 2019-10-17 | Velox Manufacturing Inc. | Wheelchair suspension |
-
1981
- 1981-02-20 JP JP56024090A patent/JPS5946928B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5946928B2 (en) | 1984-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bauer et al. | SMS 201–995: a very potent and selective octapeptide analogue of somatostatin with prolonged action | |
| BG60261B2 (en) | Lon-acting formulation of cefaclor | |
| IL99699A0 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
| FI883423A (en) | FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISK ANVAENDBARA PIPERAZINYLDERIVAT AV PURINER. | |
| MY108496A (en) | Hypoglycemic thiazolidine diones. | |
| GR3031448T3 (en) | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine. | |
| DE3687501D1 (en) | USE OF GAMMA LINOLIC ACID AND RELATED COMPOUNDS FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING COMPLICATIONS IN DIABETES MELLITUS. | |
| SE8300623D0 (en) | PHARMACEUTICAL COMPOSITION CONTAINING STABLE MICROCRISTALLIN CIS-PLATINA (II) -DIAMMINE DICHLORIDE (CISPLATIN) | |
| NO176082C (en) | Process for the Preparation of a Pharmaceutical Preparation Containing Bunazosin, for Percutaneous Delivery | |
| DK124288A (en) | LONG-TERM RELEASE PREPARATION FOR PARENTERAL SUBMISSION | |
| IE882091L (en) | Pharmaceutical compositions comprising sometostatin¹analogues | |
| NO870560D0 (en) | PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION | |
| JPS56123919A (en) | Remedy and preventive for diabetes | |
| ATE83381T1 (en) | USE OF RECOMBINATED HUMAN ALPHA INTERFERON IN THE MANUFACTURE OF A MEDICATION FOR THE TREATMENT OF THE AIDS VIRUS. | |
| JPS5626819A (en) | Preventive for hypoimmunity | |
| JPS646214A (en) | Remedy for ulcerative colonopathy | |
| HUT48265A (en) | Process for producing phosphorous-containing 2-isoxazolines and isoxazoles and pharmaceutical compositions containing them or theyr salts as active components | |
| SCHAEFFER JR | THE HEMODYNAMIC PROPERTIES OF SOUTHERN PACIFIC RATTLESNAKE, CROTALUS VIRIDIS HELLERI, VENOM AND THE HISTOCHEMISTRY OF THE SNAKE'S VENOM APPARATUS | |
| KR920007624A (en) | Composition for oral administration of protein medicine | |
| KR900015751A (en) | Composition for oral administration of protein medicine | |
| JPS6419018A (en) | Cholesterol depressing agent | |
| BG51842A1 (en) | Method for controlling the efficiency of treatment with antiarythmic composition |